Status:
NOT_YET_RECRUITING
Phenotypes Associated With Constitutional EGFR Pathogenic Variants
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Bronchopulmonary Cancers
Constitutional EGFR
Eligibility:
All Genders
18+ years
Brief Summary
A small proportion of lung cancers are hereditary, i.e. caused by a constitutional pathogenic variant (PV). EGFR " Epidermal Growth Factor Receptor " is a major cancer predisposing gene, mainly via th...
Detailed Description
A small proportion of lung cancers, particularly adenocarcinomas, is hereditary. Hereditary lung cancers occur in individuals with a genetic predisposition to the disease. It is important to remember ...
Eligibility Criteria
Inclusion
- Age ≥ 18 ans
- Carrier of a constitutional pathogenic variant of the EGFR gene
- Social security beneficiary, excluding AME
Exclusion
- Guardianship or curatorship
- Opposition to the use of data
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06562491
Start Date
September 1 2025
End Date
September 1 2025
Last Update
July 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.